# Hospira, Inc. – FDA Inspection, Nov 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/hospira-inc/f035aae9-e0b2-49a1-a514-e54edbf04704
Source feed: FDA_Inspections

> FDA inspection 1223090 of Hospira, Inc., November 14, 2023. Classification: Official Action Indicated (OAI). 1 citation under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223090
- Company Name: Hospira, Inc.
- Inspection Date: 2023-11-14
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1251941 - 2025-02-07
- [FDA Inspection 1110899 - 2019-11-21](https://www.keypedia.com/records/fda_inspections/hospira-inc/8bc1ca51-7f35-4184-ac20-80876c3d27fd)
- [FDA Inspection 1039547 - 2018-02-02](https://www.keypedia.com/records/fda_inspections/hospira-inc/ff0a477b-a209-46bc-a7b5-cd6391330701)
- FDA Inspection 984874 - 2016-05-26
- FDA Inspection 942202 - 2015-09-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)

Company: https://www.keypedia.com/companies/hospira-inc/d4decc1e-4b42-43bb-be2c-abcefbc7b965

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7